NCT05253482

Brief Summary

Background and purpose: Although wet cupping therapy (WCT) is in use, clinical investigations of its efficiency are scarce. The aim of this study was to evaluate the effects of wet cupping therapy (WCT) on fibromyalgia syndrome Methods: The patients will be randomized into two groups. WCT will be applied once a month to patients in the intervention group while the control group will be on standard therapy for fibromyalgia. An evaluation will be made before treatment and at the 3rd month using the Fibromyalgia Impact Survey (FEA), VAS, and EuroQol-5D (EQ-5D-3L) quality of life scale.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 5, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 9, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 23, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 5, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2023

Completed
Last Updated

October 5, 2023

Status Verified

October 1, 2023

Enrollment Period

1.2 years

First QC Date

February 9, 2022

Last Update Submit

October 3, 2023

Conditions

Keywords

wet cupping therapyfibromyalgia

Outcome Measures

Primary Outcomes (1)

  • Change from baseline (at 0 month) Fibromyalgia Impact Questionnaire (FIQ) scores at 3 month

    This instrument measures physical functioning, work status (missed days of work and job difficulty), depression, anxiety, morning tiredness, pain, stiffness, fatigue, and well-being over the past week.

    At 0 and 3 months

Secondary Outcomes (2)

  • Change from baseline EuroQol-5D (EQ-5D-3L) quality of life scale scores at 3 month.

    At 0 and 3 months

  • Change from baseline (At 0 month) Visual Analog Scale (VAS) scores at 3 month

    At 0 and 3 months

Study Arms (2)

Intervention group

EXPERIMENTAL

The intervention group will undergo 3 successive wet cupping therapy (WCT) sessions once in a month throughout 3 months (On 0, 30, and 60 days

Procedure: wet cupping therapy

Control group

NO INTERVENTION

Control group will not receive any intervention

Interventions

Vacuum cups will used on different acupuncture points to perform WCT: The one on the posterior median line, in the depression below the processus spinosus of the 7th cervical vertebra was DU 14 (Dazhui) point; the ones on the back, 3.0 cm lateral to the lower border of the spinous process of the 3rd thoracic vertebra interscapulum region were UB 42 (Pohu) bilateral points; and the ones on the back, 3.0 cm lateral to the lower border of the spinous process of the 7th thoracic vertebra were UB 46 (Geguan) bilateral points and additionally the patient's trigger points which we detect during the examination. There will be 5-7 points in total. The technique used will be triple S (Sucking, Scarification, Sucking) in all sessions.

Intervention group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Those who are accompanied with any chronic disease and on daily medication, contraindicated to WCT as determined in the routine blood tests that were routinely performed before the prior to application (Hgb \<9,5; INR\> 1,2,; Hgb \<9,5, etc) and who received WCT in the last three months will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Umraniye Training and Research Hospital

Istanbul, 34070, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Fibromyalgia

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Study Officials

  • Emin Pala

    Saglik Bilimleri Universitesi

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Training consultant

Study Record Dates

First Submitted

February 9, 2022

First Posted

February 23, 2022

Study Start

January 5, 2022

Primary Completion

March 5, 2023

Study Completion

July 30, 2023

Last Updated

October 5, 2023

Record last verified: 2023-10

Locations